This Israeli startup aims to catch disease early with data not diagnostic tests - MedCity News

For many diseases, early diagnosis and intervention remain key to good outcomes. That has been the rationale behind screening tests for numerous diseases including colorectal cancer. But like many startups that are looking for clues in data, Medial EarlySign -- based in Hod HaSharon, Israel -- is leveraging artificial intelligence to mine EHR data to detect colorectal cancer risk much earlier. Pushing diagnosis further upstream could have many benefits and not just for patients in terms of better outcomes. If the data reveals risk it can push people to take screening tests, that they otherwise don't take.